dimaprit has been researched along with Benign Neoplasms in 2 studies
Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, W | 1 |
| Hu, JJ | 1 |
| Song, SJ | 1 |
| Xu, Y | 2 |
| Yang, H | 1 |
| Yang, F | 1 |
| Zhou, Y | 1 |
| Yu, T | 1 |
| Qiu, WX | 1 |
| Mills, EM | 1 |
| Xu, D | 1 |
| Fergusson, MM | 1 |
| Combs, CA | 1 |
| Finkel, T | 1 |
2 other studies available for dimaprit and Benign Neoplasms
| Article | Year |
|---|---|
Aptamer-Gold Nanocage Composite for Photoactivated Immunotherapy.
Topics: Aptamers, Nucleotide; Cell Line, Tumor; Dimaprit; Gold; Humans; Immune Checkpoint Inhibitors; Immuno | 2022 |
Regulation of cellular oncosis by uncoupling protein 2.
Topics: Apoptosis; Blotting, Western; Cell Death; Cell Separation; Dimaprit; Fibroblasts; Flow Cytometry; Ge | 2002 |